Consumption of soy isoflavones reduces the risk of estrogen‐related diseases, such as menopausal symptoms, osteoporosis, and cardiovascular disease. Equol is metabolized from the isoflavone daidzein by intestinal bacteria and has higher bioavailability than other isoflavones. Equol producers are believed to benefit from soybean consumption to a greater extent than non‐producers. Recently, we showed that equol non‐producers were at significant risk of premenstrual syndrome (PMS). Previously, we reported that PMS is a common menstrual problem in female athletes, and almost half of the studied athletes felt a negative effect of premenstrual symptoms on their athletic performance. This study was conducted to evaluate the relation between PMS and equol production status in Japanese collegiate athletes.
Premenstrual symptoms interference and equol production status in Japanese collegiate athletes: A cross‐sectional study
Takashi Takeda,T. Ueno,Shigeto Uchiyama,M. Shiina
Published 2017 in The journal of obstetrics and gynaecology research
ABSTRACT
PUBLICATION RECORD
- Publication year
2017
- Venue
The journal of obstetrics and gynaecology research
- Publication date
2017-12-11
- Fields of study
Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-40 of 40 references · Page 1 of 1
CITED BY
Showing 1-9 of 9 citing papers · Page 1 of 1